BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 5812600)

  • 1. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravenously administered chlorothiazide in diagnostic evaluation of hypertensive disease.
    McGuffin WL; Gunnells JC
    Arch Intern Med; 1969 Feb; 123(2):124-30. PubMed ID: 5763614
    [No Abstract]   [Full Text] [Related]  

  • 3. Suppressed plasma renin activity in hypertension.
    Channick BJ; Adlin EV; Marks AD
    Arch Intern Med; 1969 Feb; 123(2):131-40. PubMed ID: 4303266
    [No Abstract]   [Full Text] [Related]  

  • 4. Spironolactone as a nonspecific treatment for primary aldosteronism.
    Bravo EL; Dustan HP; Tarazi RC
    Circulation; 1973 Sep; 48(3):491-8. PubMed ID: 4726231
    [No Abstract]   [Full Text] [Related]  

  • 5. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnosis and therapy of primary hyperaldosteronism].
    Hodler J
    Schweiz Med Wochenschr; 1972 Jul; 102(30):1039-44. PubMed ID: 4572955
    [No Abstract]   [Full Text] [Related]  

  • 7. Manipulation by corticotropin and cortisol of aldosterone secretion in primary aldosteronism.
    Newton MA; Laragh JH
    Arch Intern Med; 1969 Feb; 123(2):147-51. PubMed ID: 4303267
    [No Abstract]   [Full Text] [Related]  

  • 8. [Primary hyperaldosteronism].
    Plouin PF; Massien-Simon C
    Rev Prat; 1998 Apr; 48(7):749-53. PubMed ID: 11767370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on essential hypertension with suppressed plasma renin activity: sodium excretion pattern on salt restriction and effects of spironolactone on blood pressure and plasma renin activity.
    Uchida K; Morimoto S; Takeda R; Murakami M
    Jpn Circ J; 1972 Dec; 36(12):1301-11. PubMed ID: 4679217
    [No Abstract]   [Full Text] [Related]  

  • 10. Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?
    Morimoto S; Takeda R; Murakami M
    J Clin Endocrinol Metab; 1970 Dec; 31(6):659-64. PubMed ID: 4921649
    [No Abstract]   [Full Text] [Related]  

  • 11. [Endocrinologic and circulatory findings in a case of primary aldosteronism].
    Marsen B; Dissmann T; Oelkers W; Lohmann FW; Molzahn M; Gotzen R
    Dtsch Med Wochenschr; 1971 May; 96(22):951-4. PubMed ID: 5578596
    [No Abstract]   [Full Text] [Related]  

  • 12. [The screening of primary aldosteronism with PRA and urinary Na/K after the furosemide test (author's transl)].
    Itoh T; Abe K; Gotoh T; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1982 Mar; 71(3):312-8. PubMed ID: 7050266
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary aldosteronism -- screening, diagnosis and therapy.
    Horký K; Gregorová I; Vancura J; Silinková-Málková E; Hradec E
    Cor Vasa; 1981; 23(4):265-79. PubMed ID: 7028394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary aldosteronism: case report with plasma renin suppression.
    Maroon JC; Lukemeyer GT
    J Indiana State Med Assoc; 1967 Jan; 60(1):27-30. PubMed ID: 6036118
    [No Abstract]   [Full Text] [Related]  

  • 15. [Diagnosis of primary hyperaldosteronism].
    Diederich S; Bidlingmaier M; Quinkler M; Reincke M
    Med Klin (Munich); 2007 Jan; 102(1):16-21. PubMed ID: 17221347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary aldosteronism.
    Biglieri EG
    Curr Ther Endocrinol Metab; 1994; 5():152-5. PubMed ID: 7704703
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
    Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
    Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypokalemic and normokalemic primary aldosteronism. A contribution to the differential diagnosis of essential hypertonia].
    Wolff HP; Barth C; Distler A; Düsterdieck G; Krück F; Roscher S; Vecsei P; Weinges KF
    Dtsch Med Wochenschr; 1969 Apr; 94(15):760-4 passim. PubMed ID: 5777258
    [No Abstract]   [Full Text] [Related]  

  • 19. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saline suppression of plasma aldosterone and plasma renin activity in hypertension.
    Kem DC; Mayes D; Weinberger M; Nugent CA
    Ariz Med; 1971 Apr; 28(4):264-6. PubMed ID: 5572938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.